Home/Filings/4/A/0001628280-25-034186
4/A//SEC Filing

Strobeck Mark 4/A

Accession 0001628280-25-034186

CIK 0001041024other

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 1:26 PM ET

Size

5.4 KB

Accession

0001628280-25-034186

Insider Transaction Report

Form 4/AAmended
Period: 2025-07-01
Strobeck Mark
DirectorPresident and CEO
Transactions
  • Sale

    Common Stock

    2025-07-01$0.82/sh6,926$5,679337,752 total
Footnotes (1)
  • [F1]This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024 in multiple trades at prices ranging from $0.81 to $0.84. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Issuer

ROCKWELL MEDICAL, INC.

CIK 0001041024

Entity typeother

Related Parties

1
  • filerCIK 0001599219

Filing Metadata

Form type
4/A
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 1:26 PM ET
Size
5.4 KB